Kai‐Uwe Eckardt

63.7k total citations · 15 hit papers
486 papers, 33.5k citations indexed

About

Kai‐Uwe Eckardt is a scholar working on Nephrology, Hematology and Molecular Biology. According to data from OpenAlex, Kai‐Uwe Eckardt has authored 486 papers receiving a total of 33.5k indexed citations (citations by other indexed papers that have themselves been cited), including 147 papers in Nephrology, 129 papers in Hematology and 92 papers in Molecular Biology. Recurrent topics in Kai‐Uwe Eckardt's work include Erythropoietin and Anemia Treatment (116 papers), Dialysis and Renal Disease Management (75 papers) and Cancer, Hypoxia, and Metabolism (68 papers). Kai‐Uwe Eckardt is often cited by papers focused on Erythropoietin and Anemia Treatment (116 papers), Dialysis and Renal Disease Management (75 papers) and Cancer, Hypoxia, and Metabolism (68 papers). Kai‐Uwe Eckardt collaborates with scholars based in Germany, United States and United Kingdom. Kai‐Uwe Eckardt's co-authors include Bertram L. Kasiske, Andrew S. Levey, Josef Coresh, Adeera Levin, Michael S. Wiesener, Jérôme Rossert, Ulrich Frei, Norbert Lameire, Garabed Eknoyan and Carsten Willam and has published in prestigious journals such as New England Journal of Medicine, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Kai‐Uwe Eckardt

468 papers receiving 32.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Definition and classification of chronic kidney disease: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)

2005 2.8k citations Andrew S. Levey, Kai‐Uwe Eckardt et al. profile →
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report

2010 1.7k citations Andrew S. Levey, Kai‐Uwe Eckardt et al. profile →
Normalization of Hemoglobin Level in Patients with Chronic Kidney Disease and Anemia

2006 1.5k citations Kai‐Uwe Eckardt et al. profile →
Chronic kidney disease as a global public health problem: Approaches and initiatives – a position statement from Kidney Disease Improving Global Outcomes

2007 1.1k citations Andrew S. Levey, Kai‐Uwe Eckardt et al. profile →
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients

2009 1.1k citations Kai‐Uwe Eckardt et al. profile →
Evolving importance of kidney disease: from subspecialty to global health burden

2013 796 citations Kai‐Uwe Eckardt, Anna Köttgen et al. profile →
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO)

2011 653 citations Kai‐Uwe Eckardt et al. profile →
KDIGO Clinical Practice Guideline for Glomerulonephritis

2012 652 citations Kai‐Uwe Eckardt et al. profile →
Widespread, hypoxia‐inducible expression of HIF‐2α in distinct cell populations of different organs

2002 582 citations Michael S. Wiesener, Jan Steffen Jürgensen et al. profile →
Induction of Endothelial PAS Domain Protein-1 by Hypoxia: Characterization and Comparison With Hypoxia-Inducible Factor-1α

1998 539 citations Michael S. Wiesener, Carsten Willam et al. profile →
Kidney Disease: Improving Global Outcomes

2009 485 citations Kai‐Uwe Eckardt et al. Nature Reviews Nephrology profile →
Expression of Hypoxia-Inducible Factor-1α and -2α in Hypoxic and Ischemic Rat Kidneys

2002 480 citations Christian Rosenberger, Michael S. Wiesener et al. Journal of the American Society of Nephrology profile →
Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

2015 384 citations Kai‐Uwe Eckardt et al. profile →
Change in Albuminuria and GFR as End Points for Clinical Trials in Early Stages of CKD: A Scientific Workshop Sponsored by the National Kidney Foundation in Collaboration With the US Food and Drug Administration and European Medicines Agency

2019 314 citations Andrew S. Levey, Kai‐Uwe Eckardt et al. profile →
Kidney physiology and susceptibility to acute kidney injury: implications for renoprotection

2021 197 citations Kai‐Uwe Eckardt, Pontus B. Persson et al. Nature Reviews Nephrology profile →

Peers

Countries citing papers authored by Kai‐Uwe Eckardt

Since Specialization

Citations

This map shows the geographic impact of Kai‐Uwe Eckardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai‐Uwe Eckardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai‐Uwe Eckardt more than expected).

Fields of papers citing papers by Kai‐Uwe Eckardt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai‐Uwe Eckardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai‐Uwe Eckardt. The network helps show where Kai‐Uwe Eckardt may publish in the future.

Co-authorship network of co-authors of Kai‐Uwe Eckardt

This figure shows the co-authorship network connecting the top 25 collaborators of Kai‐Uwe Eckardt. A scholar is included among the top collaborators of Kai‐Uwe Eckardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai‐Uwe Eckardt. Kai‐Uwe Eckardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Vascular Access Thrombosis Events in Patients With Dialysis-Dependent CKD Treated With Vadadustat or Darbepoetin Alfa: The INNO2VATE Trial Program 2025 ·Kidney Medicine ·Wolfgang C. Winkelmayer, Steven K. Burke, Glenn M. Chertow, Kai‐Uwe Eckardt, Wei Luo, Todd Minga, Mark J. Sarnak, Prabir Roy‐Chaudhury	2
2	Kidney transplantation in patients with polycystic kidney disease: increased risk of infection does not compromise graft and patient survival 2024 ·Clinical Kidney Journal ·Johannes Waiser, Jens Klotsche, Petra Glander, (unknown), Marcel G. Naik, Lutz Liefeldt, Klemens Budde, Jan Halbritter, Fabian Halleck, Bianca Zukunft, Robert W. Peters, Frank Friedersdorff, Nils Lachmann, Kai‐Uwe Eckardt, (unknown), Friederike Bachmann	1
3	Welchen Einfluss hat die Entfernung zwischen dem Notfallort und dem ECLS-Zentrum auf die Low-Flow-Zeit von ECPR-Patienten? 2024 ·Notarzt ·(unknown), (unknown), Jens Nee, Daniel Zickler, Roland Körner, (unknown), (unknown), Uwe Hoff, Kai‐Uwe Eckardt, Jan Matthias Kruse	0
4	β2-integrins control HIF1α activation in human neutrophils 2024 ·Frontiers in Immunology ·(unknown), (unknown), Uwe Jerke, Anthony Rousselle, Kai‐Uwe Eckardt, Adrian Schreiber, Ralph Kettritz	1
5	Pregnancy after Kidney Transplantation—Impact of Functional Renal Reserve, Slope of eGFR before Pregnancy, and Intensity of Immunosuppression on Kidney Function and Maternal Health 2023 ·Journal of Clinical Medicine ·(unknown), (unknown), Friederike Bachmann, Nils Lachmann, Nadine Koch, Bianca Zukunft, Kaiyin Wu, Danilo Schmidt, Fabian Halleck, Peter Nickel, Kai‐Uwe Eckardt, Klemens Budde, Stefan Verlohren, Mira Choi	4
6	KLKB1 and CLSTN2 are associated with HDL-mediated cholesterol efflux capacity in a genome-wide association study 2023 ·Atherosclerosis ·(unknown), Sebastian Schönherr, Claudia Lamina, Lukas Forer, Stefan Coassin, (unknown), (unknown), Yong Li, Heike Meiselbach, Silvia Di Maio, Kai‐Uwe Eckardt, Anna Köttgen, Florian Kronenberg	3
7	Genetics of osteopontin in patients with chronic kidney disease: The German Chronic Kidney Disease study 2022 ·PLoS Genetics ·Yurong Cheng, Yong Li, (unknown), Franziska Grundner-Culemann, Terho Lehtimäki, (unknown), Olli T. Raitakari, Matthias Nauck, Kai‐Uwe Eckardt, Peggy Sekula, Ulla T. Schultheiß, (unknown)	9
8	B and T Cell Responses after a Third Dose of SARS-CoV-2 Vaccine in Kidney Transplant Recipients 2021 ·Journal of the American Society of Nephrology ·Eva Schrezenmeier, Héctor Rincón-Arévalo, Ana‐Luisa Stefanski, (unknown), (unknown), Mira Choi, Friederike Bachmann, (unknown), (unknown), Hubert Schrezenmeier, Carolin Ludwig, Bernd Jahrsdörfer, Andreia C. Lino, Kai‐Uwe Eckardt, Katja Kotsch, Thomas Dörner, Klemens Budde, Arne Sattler, Fabian Halleck	61
9	Altered increase in STAT1 expression and phosphorylation in severe COVID‐19 2021 ·European Journal of Immunology ·Héctor Rincón-Arévalo, (unknown), Jacob Ritter, Franziska Szelinski, (unknown), Daniel Zickler, Ana‐Luisa Stefanski, Andreia C. Lino, Sixten Körper, Kai‐Uwe Eckardt, Hubert Schrezenmeier, Thomas Dörner, Eva Schrezenmeier	35
10	Nomenclature for kidney function and disease: executive summary from a KDIGO consensus conference 2020 ·Nature Reviews Nephrology ·Andrew S. Levey, Kai‐Uwe Eckardt, Nijsje Dorman, Stacy Christiansen, Michael Cheung, Michel Jadoul, Wolfgang C. Winkelmayer	3
11	Zinc Inhibits Phosphate-Induced Vascular Calcification through TNFAIP3-Mediated Suppression of NF-κB 2018 ·Journal of the American Society of Nephrology ·Jakob Voelkl, Rashad Tuffaha, Trang T. D. Luong, Daniel Zickler, (unknown), Martina Feger, Nicolas Verheyen, Florian Blaschke, Makoto Kuro‐o, Andreas Tomaschitz, Stefan Pilz, Andreas Pasch, Kai‐Uwe Eckardt, J E Scherberich, Florian Läng, Burkert Pieske, Ioana Alesutan	131
12	A dual role of miR‐22 in rhabdomyolysis‐induced acute kidney injury 2018 ·Acta Physiologica ·Susanne Mathia, (unknown), Mumtaz Kasim, Karin M. Kirschner, Pontus B. Persson, Kai‐Uwe Eckardt, Christian Rosenberger, Michael Fähling	10
13	From Discovery to Translation: Characterization of C-Mannosyltryptophan and Pseudouridine as Markers of Kidney Function 2017 ·Scientific Reports ·Peggy Sekula, Katja Dettmer, (unknown), Wolfram Gronwald, Lisa Ellmann, Robert P. Mohney, Kai‐Uwe Eckardt, Karsten Suhre, Gabi Kastenmüller, Peter J. Oefner, Anna Köttgen	26
14	Genetic variation at the 8q24.21 renal cancer susceptibility locus affects HIF binding to a MYC enhancer 2016 ·Nature Communications ·Steffen Grampp, (unknown), (unknown), Rafik Salama, (unknown), (unknown), Sven Wach, Christine Stöhr, Arndt Hartmann, Kai‐Uwe Eckardt, Peter J. Ratcliffe, David R. Mole, Johannes Schödel	62
15	²³ Na Magnetic Resonance Imaging of Tissue Sodium 2011 ·Hypertension ·Christoph Kopp, Peter Linz, Lydia Wachsmuth, Anke Dahlmann, Thomas Horbach, Christof Schöfl, Wolfgang Renz, Davide Santoro, Thoralf Niendorf, Dominik N. Müller, (unknown), Alexander Cavallaro, Kai‐Uwe Eckardt, Roland E. Schmieder, Friedrich C. Luft, Michael Uder, Jens Titze	197
16	Mononuclear Phagocyte System Depletion Blocks Interstitial Tonicity-Responsive Enhancer Binding Protein/Vascular Endothelial Growth Factor C Expression and Induces Salt-Sensitive Hypertension in Rats 2010 ·Hypertension ·(unknown), Anke Dahlmann, Christoph Kopp, Jennifer Goss, Hubertus Wagner, Nico van Rooijen, Kai‐Uwe Eckardt, Dominik N. Müller, Joon-Keun Park, Friedrich C. Luft, Dontscho Kerjaschki, Jens Titze	161
17	Studies on Renal Disorders 2010 ·Humana Press eBooks ·Toshio Miyata, Masaomi Nangaku, Kai‐Uwe Eckardt	21
18	Mutual Regulation of Hypoxia-Inducible Factor and Mammalian Target of Rapamycin as a Function of Oxygen Availability 2009 ·Molecular Cancer Research ·Karl X. Knaup, Katrin Jozefowski, Regina Schmidt, Wanja M. Bernhardt, Alexander Weidemann, (unknown), Christina Warnecke, Kai‐Uwe Eckardt, Michael S. Wiesener	46
19	Donor treatment with a PHD-inhibitor activating HIFs prevents graft injury and prolongs survival in an allogenic kidney transplant model 2009 ·Proceedings of the National Academy of Sciences ·Wanja M. Bernhardt, Uwe Göttmann, (unknown), Bjoern Buchholz, Valentina Câmpean, Johannes Schödel, (unknown), S J Klaus, Michael Arend, Lee A. Flippin, Carsten Willam, Michael S. Wiesener, Benito Yard, C. Warnecke, Kai‐Uwe Eckardt	119
20	Bone morphogenic protein-4 expression in vascular lesions of calciphylaxis 2003 ·Journal of Nephrology ·Wanja Griethe, Roland Schmitt, Jan Steffen Jürgensen, Sebastian Bachmann, Kai‐Uwe Eckardt, Ralf Schindler	35

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact